Bluejay Diagnostics annual free cash flow
2021
2022
2023
2024
2025
Bluejay Diagnostics reported −$6.2M in free cash flow for fiscal 2025, an increase of $1.9M from the previous fiscal year.
View full Bluejay Diagnostics company overview| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$6.2M | $1.9M | — | — |
| 2024 | 2024-12-31 | −$8.1M | $890,431 | — | — |
| 2023 | 2023-12-31 | −$9.0M | −$77,173 | — | — |
| 2022 | 2022-12-31 | −$8.9M | −$4.6M | — | −3590.13% |
| 2021 | 2021-12-31 | −$4.4M | — | — | — |
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$1.6M | $542,791 | — | — |
| Q1 2026 | 2026-03-31 | −$1.6M | $727,213 | — | — |
| Q4 2024 | 2024-12-31 | −$1.5M | $1.4M | — | — |
| Q3 2024 | 2024-09-30 | −$2.2M | −$955,249 | — | — |
| Q2 2024 | 2024-06-30 | −$2.2M | −$506,095 | — | — |
| Q1 2024 | 2024-03-31 | −$2.3M | $938,874 | — | — |
| Q4 2023 | 2023-12-31 | −$2.9M | $317,079 | — | — |
| Q3 2023 | 2023-09-30 | −$1.2M | $852,933 | — | — |
| Q2 2023 | 2023-06-30 | −$1.7M | $103,490 | — | — |
| Q1 2023 | 2023-03-31 | −$3.3M | −$1.4M | — | — |
| Q4 2022 | 2022-12-31 | −$3.2M | −$2.1M | — | — |
| Q3 2022 | 2022-09-30 | −$2.1M | — | — | — |
| Q2 2022 | 2022-06-30 | −$1.8M | — | — | −715.67% |
| Q1 2022 | 2022-03-31 | −$1.9M | — | — | — |
| Q3 2021 | 2021-09-30 | −$1.1M | — | — | — |
Bluejay Diagnostics's latest reported quarter, Q2 2026, generated −$1.6M in free cash flow, an increase of $542,791 year over year.
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Bluejay Diagnostics filings at SEC.gov ↗